Oh, not the old Ibogaine con game again!
LadyDoc:
This is a new variation of an old lie.
I'd say there's a greater than 90% probability that you two are correct and that this stuff would not pan out - that either the results are exaggerated, or that there are side effects that would be unacceptable, or both.
But, I have two questions for both of you:
1. Do you favor at least finding out what the effects of ibogaine on addiction are? (In humans that is - the previous research cited by 45Auto was all on rats.)
After all, since it's never been tried on people except for this rather sensationalized incident reported in the article, it's at least remotely possible that in the right dosage, it could be an effective tool for treating addiction. So, in the interest of finding a way to deal with addition, you would be in favor of further research, right? Or if not, why not?
2. Let's just suppose that this stuff does pan out, and is effective in treating addiction, with side effects that were either minor or controllable. Would you have any object to its usage to treat addition, even though it would be a "short-cut" over full scale withdrawal? Or would you prefer for people to endure regular withdrawal?
I'm guessing from your other posts that the two of you would give completely different answers to these questions.
The melotonin angle is interesting, nothing like a good nights sleep, n'est pas?
Mounting a Phase I clinical study in humans with ibogaine faces several hurdles: the drug is listed as a Schedule I controlled substance. Obtaining approval for study of those drugs would be very expensive and there are political/legal considerations which are even more formidable. I don't know if an IND (Investigational New Drug) application is on file with the FDA; if not, we are talking about a considerable amount of animal work (and money) which would be necessary in order to apply for and IND. A controlled Phase I human clinical trial would cost something in 7 figures to mount.